Telogen Effluvium: Potential causes in Iraq


  • Alaa Abdulhassan Naif M.B.Ch.B, M.Sc. (Dermatol) , School of Medicine / Thi-Qar University


Hair loss, Telogen Effluvium, Thyroid Stimulating Hormone, Serum Ferritin, Vitamin D3


Background: Telogen Effluvium (TE) among women is a challenging common problem for Dermatologists and data on its prevalence among Iraqi women is limited hair loss is a distressing problem for women because femininity and attractiveness is linked to women's hair. Aim of study: To find out the main risk factors of Telogen Effluvium among women in Thi-Qar Province ( Iraq ). Some of these risk factors are investigated before in Iraq but not in Thi-Qar province such as TSH while others such as Vitamin D are barely investigated in Iraq. Patients and methods: A descriptive cross sectional study carried out in Dermatology Outpatient Clinic of Al-Hussein Teaching Hospital, Nassiriah City ( Thi-Qar Province Center), Iraq through the period from 1st of March, 2014 to the end of June, 2015 on random sample of 100 women with Telogen Effluvium and convenient sample of 100 healthy controls. Thyroid stimulating hormone, serum Ferritin and Vitamin D3 levels of both groups were measured. Results: There was a significant association between positive family history of hair loss and women with Telogen Effluvium (p<0.001). No significant difference in thyroid stimulating hormone level was observed between cases and controls (p=0.6). There was a significantly lower serum Ferritin and Vitamin D3 levels among women with Telogen Effluvium (p<0.05). Conclusion: Low serum Ferritin and Vitamin D3 levels among women might play a major role in etiology of Telogen Effluvium.


Moeinvaziri M, Mansoori P, Holakooee K, NaraghiSZ, Abbasi A. Iron status in diffuse telogen hair loss among women, ActaDermatovenerol Croat 2009; 17(4):279-284.

Rasheed H, Mahgoub D, Hegazy R, El-Komy M, Abdel Hay R, Hamid MA, et al. Serum ferritin and vitamin d in female hair loss: do they play a role? Skin Pharmacol Physiol 2013; 26(2):101-107.

Shapiro J. Hair Loss in Women. N Engl J Med 2007; 357:1620-1630.

Vujovic A, Del Marmol V. The female pattern hair loss: Review of etiopathogenesis and diagnosis. BioMed Research International 2014 (1): 767628.

Karadağ AS, Ertuğrul DT, Tutal E, Akin KO. The role of anemia and vitamin D levels in acute and chronic telogen effluvium. Turkish Journal of Medical Sciences 2011; 41 (5): 827-833.

Bregy A, Trueb RM. No association between serum ferritin levels >10 microg/l and hair loss activity in women. Dermatology 2008; 217: 1–6.

Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003; 121: 985–988.

Rushton DH. Decreased serum ferritin and alopecia in women. J Invest Dermatol 2003; 121: xvii–xviii.

Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol 2002; 147: 982–984.

Olsen EA, Reed KB, Cacchio PB, Caudill L. Iron deficiency in female pattern hair loss, chronic telogen effluvium and control groups. J Am AcadDermatol 2010; 63: 991–999.

Kennedy A, Kohn M, Lammi A, Clarke S. Iron status and haematological changes in adolescent female in patients with anorexia nervosa. J Paediatr Child Health 2004; 40: 430–432.

Reichrath J. Vitamin D and the skin: an ancient friend, revisited. ExpDermatol 2007; 16: 618-625.

Zlotogorski A, Hochberg Z, Mirmirani P, Metzker A, BenAmitai D, Martinez-Mir A, et al. Clinical and pathologic correlations in genetically distinct forms of atrichia. Arch Dermatol 2003; 139: 1591-1596.

Olsen EA. Female pattern hair loss. J Am AcadDermatol 2001; 45:S70-80.

Charan J, Biswas T. How to calculate sample size for different study designs in medical research. Indian J Psychol Med 2013; 35 (2):121-126.

Springer K, Brown M, Stulberg DL. Common hair loss disorders. Am Fam Physician 2003; 68: 93-108.

Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol 2002; 27: 389-395.

França K, Rodrigues T, Ledon J, Savas J, Chacon A. Comprehensive Overview and Treatment Update on Hair Loss. Journal of Cosmetics, Dermatological Sciences and Applications 2013; 3 (3A): 1-8.

Fatani MI, Bin mahfoz AM, Mahdi AH, Alafif KA, Hussain WA Khan AS, et al. Prevalence and factors associated with telogen

effluvium in adult females at Makkah region, Saudi Arabia: A retrospective study. Journal of Dermatology & Dermatologic Surgery2015; 19: 27–30.

Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 1992; 7:145-153.

Liau G, Chan LM, Feng P. Increased ferritin gene expression is both promoted by cAMP and a marker of growth arrest in rabbit vascular smooth muscle cells. J BiolChem 1991; 266:1819-1826.

Elledge SJ, Zhou Z, Allen JB. Ribonucleotide reductase: regulation, regulation, regulation. Trends BiochemSci 1992; 17:119-123.

Amor K, Rashid R, Mirmirani P. Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J 2010; 16:3.

Zheng Y, Prouty SM, Harmon A, Sundberg JP, Stenn KS, Parimoo S: Scd3 – a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics 2001; 71: 182–191.

Demay MB: The hair cycle and vitamin D receptor. Arch Biochem Biophys 2012; 523: 19–21.